vs
Side-by-side financial comparison of GE HealthCare (GEHC) and PG&E Corporation (PCG). Click either name above to swap in a different company.
PG&E Corporation is the larger business by last-quarter revenue ($6.9B vs $5.7B, roughly 1.2× GE HealthCare). PG&E Corporation runs the higher net margin — 12.9% vs 10.3%, a 2.5% gap on every dollar of revenue. On growth, PG&E Corporation posted the faster year-over-year revenue change (15.0% vs 7.1%). Over the past eight quarters, GE HealthCare's revenue compounded faster (10.7% CAGR vs 7.2%).
GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures...
Pacific Gas and Electric Company (PG&E) is an American investor-owned utility (IOU). The company is headquartered at Kaiser Center, in Oakland, California. PG&E provides natural gas and electricity to 5.2 million households in the northern two-thirds of California, from Bakersfield and northern Santa Barbara County, almost to the Oregon and Nevada state lines.
GEHC vs PCG — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $5.7B | $6.9B |
| Net Profit | $588.0M | $885.0M |
| Gross Margin | 39.7% | — |
| Operating Margin | 14.5% | 21.4% |
| Net Margin | 10.3% | 12.9% |
| Revenue YoY | 7.1% | 15.0% |
| Net Profit YoY | -18.4% | 39.6% |
| EPS (diluted) | $1.28 | $0.39 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $6.9B | ||
| Q4 25 | $5.7B | $6.8B | ||
| Q3 25 | $5.1B | $6.3B | ||
| Q2 25 | $5.0B | $5.9B | ||
| Q1 25 | $4.8B | $6.0B | ||
| Q4 24 | $5.3B | $6.6B | ||
| Q3 24 | $4.9B | $5.9B | ||
| Q2 24 | $4.8B | $6.0B |
| Q1 26 | — | $885.0M | ||
| Q4 25 | $588.0M | $670.0M | ||
| Q3 25 | $446.0M | $850.0M | ||
| Q2 25 | $486.0M | $549.0M | ||
| Q1 25 | $564.0M | $634.0M | ||
| Q4 24 | $721.0M | $674.0M | ||
| Q3 24 | $470.0M | $579.0M | ||
| Q2 24 | $428.0M | $524.0M |
| Q1 26 | — | — | ||
| Q4 25 | 39.7% | — | ||
| Q3 25 | 38.7% | — | ||
| Q2 25 | 39.6% | — | ||
| Q1 25 | 42.1% | — | ||
| Q4 24 | 42.8% | — | ||
| Q3 24 | 41.7% | — | ||
| Q2 24 | 41.4% | — |
| Q1 26 | — | 21.4% | ||
| Q4 25 | 14.5% | 18.0% | ||
| Q3 25 | 12.7% | 19.3% | ||
| Q2 25 | 13.1% | 18.6% | ||
| Q1 25 | 13.2% | 20.4% | ||
| Q4 24 | 15.1% | 15.4% | ||
| Q3 24 | 13.9% | 17.3% | ||
| Q2 24 | 12.6% | 18.9% |
| Q1 26 | — | 12.9% | ||
| Q4 25 | 10.3% | 9.8% | ||
| Q3 25 | 8.7% | 13.6% | ||
| Q2 25 | 9.7% | 9.3% | ||
| Q1 25 | 11.8% | 10.6% | ||
| Q4 24 | 13.6% | 10.2% | ||
| Q3 24 | 9.7% | 9.7% | ||
| Q2 24 | 8.8% | 8.8% |
| Q1 26 | — | $0.39 | ||
| Q4 25 | $1.28 | $0.29 | ||
| Q3 25 | $0.98 | $0.37 | ||
| Q2 25 | $1.06 | $0.24 | ||
| Q1 25 | $1.23 | $0.28 | ||
| Q4 24 | $1.58 | $0.30 | ||
| Q3 24 | $1.02 | $0.27 | ||
| Q2 24 | $0.93 | $0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.5B | — |
| Total DebtLower is stronger | $10.0B | — |
| Stockholders' EquityBook value | $10.4B | — |
| Total Assets | $36.9B | — |
| Debt / EquityLower = less leverage | 0.96× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $4.5B | $713.0M | ||
| Q3 25 | $4.0B | $404.0M | ||
| Q2 25 | $3.7B | $494.0M | ||
| Q1 25 | $2.5B | $2.0B | ||
| Q4 24 | $2.9B | $940.0M | ||
| Q3 24 | $3.5B | $895.0M | ||
| Q2 24 | $2.0B | $1.3B |
| Q1 26 | — | — | ||
| Q4 25 | $10.0B | $57.4B | ||
| Q3 25 | $10.3B | — | ||
| Q2 25 | $10.3B | — | ||
| Q1 25 | $8.8B | — | ||
| Q4 24 | $9.0B | $53.6B | ||
| Q3 24 | $10.3B | — | ||
| Q2 24 | $9.2B | — |
| Q1 26 | — | — | ||
| Q4 25 | $10.4B | $32.5B | ||
| Q3 25 | $10.0B | $32.0B | ||
| Q2 25 | $9.7B | $31.2B | ||
| Q1 25 | $9.2B | $30.7B | ||
| Q4 24 | $8.4B | $30.1B | ||
| Q3 24 | $8.3B | $26.8B | ||
| Q2 24 | $7.8B | $26.3B |
| Q1 26 | — | — | ||
| Q4 25 | $36.9B | $141.6B | ||
| Q3 25 | $36.1B | $138.2B | ||
| Q2 25 | $35.5B | $136.4B | ||
| Q1 25 | $33.6B | $135.4B | ||
| Q4 24 | $33.1B | $133.7B | ||
| Q3 24 | $33.9B | $132.3B | ||
| Q2 24 | $31.9B | $130.8B |
| Q1 26 | — | — | ||
| Q4 25 | 0.96× | 1.76× | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 1.06× | — | ||
| Q1 25 | 0.95× | — | ||
| Q4 24 | 1.06× | 1.78× | ||
| Q3 24 | 1.24× | — | ||
| Q2 24 | 1.18× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GEHC
| Imaging Segment | $2.6B | 45% |
| PCS Segment | $824.0M | 14% |
| P Dx Segment | $790.0M | 14% |
| Specialized Ultrasound Subsegment | $735.0M | 13% |
| Monitoring Solutions Subsegment | $578.0M | 10% |
| Life Support Solutions Subsegment | $247.0M | 4% |
PCG
| Electric | $5.0B | 72% |
| Other | $1.9B | 28% |
